AYTU compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

AYTUAytu Biopharma, Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

AYTUAytu Biopharma, Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AYTUAytu Biopharma, Inc

1.82▼−5.47%· post 1.82

Mkt cap$20.9MRevenue$16MQ4 FY26Revenue$58MFY26

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

AYTUAytu Biopharma, Inc

LLYELI Lilly & Co

1.82▼−5.47%post 1.82

Price

1,371.32▼−3.29%post 1,363.77

$20.9M

Mkt cap

$1.2T

Q4 FY26$16M

Revenue

$24.4BQ3 FY26

FY26$58M

Revenue

$65.2BFY25

AYTU1.82▼−5.47%vsLLY1,371.32▼−3.29%ClosedNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AYTU: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AYTU 7

—Halo Pharmaceuticalunlistedsupplier

—Mission Pharmacalunlistedsupplier

—Tris Pharmaunlistedsupplier

—Fabre-Kramerunlistedsupplier

3 more · AYTU chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

AYTU, solidLLY, dashed